Antimetabolites, Antineoplastic
"Antimetabolites, Antineoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antimetabolites that are useful in cancer chemotherapy.
Descriptor ID |
D000964
|
MeSH Number(s) |
D27.505.519.186.144 D27.505.954.248.144 D27.888.569.042.030
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antimetabolites, Antineoplastic".
Below are MeSH descriptors whose meaning is more specific than "Antimetabolites, Antineoplastic".
This graph shows the total number of publications written about "Antimetabolites, Antineoplastic" by people in this website by year, and whether "Antimetabolites, Antineoplastic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
2003 | 1 | 0 | 1 |
2005 | 1 | 0 | 1 |
2008 | 1 | 1 | 2 |
2012 | 1 | 1 | 2 |
2014 | 0 | 1 | 1 |
2015 | 1 | 0 | 1 |
2017 | 16 | 6 | 22 |
2018 | 8 | 7 | 15 |
2019 | 3 | 4 | 7 |
2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Antimetabolites, Antineoplastic" by people in Profiles.
-
NICEdrug.ch, a workflow for rational drug design and systems-level analysis of drug metabolism. Elife. 2021 08 03; 10.
-
Population pharmacokinetic and pharmacodynamic modeling of capecitabine and its metabolites in breast cancer patients. Cancer Chemother Pharmacol. 2021 02; 87(2):229-239.
-
Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients. Blood Adv. 2020 12 08; 4(23):5936-5941.
-
Repeat-positive SARS-CoV-2 in a child with cancer. Pediatr Blood Cancer. 2021 03; 68(3):e28744.
-
SARS-CoV-2 infection in a 7-year-old girl with pancytopenia during acute lymphocytic leukemia maintenance therapy. Pediatr Blood Cancer. 2020 11; 67(11):e28391.
-
Poly(3-hydroxybutyrate-CO-3-hydroxyvalerate) PHBHV biocompatible nanocarriers for 5-FU delivery targeting colorectal cancer. Drug Deliv. 2019 Dec; 26(1):318-327.
-
Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer: A case report. Medicine (Baltimore). 2019 Sep; 98(37):e17135.
-
Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment. Medicine (Baltimore). 2019 Jul; 98(30):e16482.
-
Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study. Anticancer Res. 2019 Jun; 39(6):3095-3100.
-
ARA-C RELATED RED EAR SYNDROME. Ear Nose Throat J. 2019 Mar; 98(3):169-170.